Meet our Board Members

The board oversees the strategic direction of the organisation with a focus on all governance issues and associated business functions. It decides on major directions and policies, provides accountability and ensures proper management.

Helen Kurincic

Chair of the Board

Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, HBF Health Limited and the Victorian Clinical Genetics Service.

Read more >

Rob De Luca

Chief Executive Officer

Having joined MMS in 2022, Mr De Luca has over 20 years’ experience in Financial Services, Wealth Management, Disability and Healthcare, including roles as…

Read more >

Bruce Akhurst

Non-Executive Director
Chairman of the People, Culture and Remuneration Committee

Mr Akhurst is currently the Chairman of Tabcorp Holdings Limited and a member of the Audit Committee, Technology Committee, Nomination Committee…

Read more >

Kathy Parsons

Non-Executive Director
Chair of the Audit, Risk and Compliance Committee

Ms Parsons is a former audit partner at Ernst & Young where she spent time as a partner in the firm’s US, UK and Australian practices

Read more >

John Bennetts

Non-Executive Director

Mr Bennetts is an experienced investor and has been the founder and director of many successful Australian companies…

Read more >

Ross Chessari

Non-Executive Director

Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures).

Read more >

Tim Poole

Non-Executive Director

Mr Poole is currently Chairman of Aurizon Holdings Limited and a Non-Executive Director of Reece Limited.

Read more >

Tim Poole

Non-Executive Director

Mr Poole is currently Chairman of Aurizon Holdings Limited and a Non-Executive Director of Reece Limited. Mr Poole was previously an executive of the unlisted infrastructure and private equity manager, Hastings Funds Management (1995 to 2007), including being the Managing Director from 2005. He was formerly the Non-Executive Chairman of Lifestyle Communities Limited. Mr Poole is considered an independent director under the Company’s definition of independence. Mr Poole is a member of the Audit, Risk & Compliance Committee and the Remuneration and Nomination Committee.

John Bennetts BEc, LLB

Non-Executive Director

Mr Bennetts is an experienced investor and has been the founder and director of many successful Australian companies with businesses in technology, finance and manufacturing. Mr Bennetts is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also previously provided advisory services to a range of companies in Australia and Asia. Prior to the establishment of the M-Group, he was a member of the senior executive of the pioneering Australian multinational IT company, Datacraft Limited. Mr Bennetts is a member of the Audit, Risk and Compliance Committee

Ross Chessari LLB, MTax

Non-Executive Director

Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures).  Prior to founding SciVentures, Mr Chessari was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees. Mr Chessari is a member of the Remuneration & Nomination Committee.

Ian Elliot

Non-Executive Director Chairman of the Remuneration & Nomination Committee

Mr Elliot is Non-Executive Chairman of the Dry July Foundation. Formerly, Mr Elliot was a Non-Executive Chairman of Impelus Limited (2017-2018) and and Non-Executive Director of Salmat Limited (2005-2016), Hills Industries Limited (2003-2016) and the Australian Rugby League Commission (2012-2016). Mr Elliot was previously Chairman and CEO at Australia’s largest advertising agency George Patterson Bates, is a Fellow of the Australian Institute of Company Directors and a graduate of the Advanced Management Program at Harvard Business School. Mr Elliot is considered an independent director under the Company’s definition of independence.

Helen Kurincic

Chair of the Board

Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, HBF Health Limited and the Victorian Clinical Genetics Service. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its earliest inception, creating and developing the first and largest radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. Ms Kurincic is a Fellow of the Australian Institute of Company Directors. Ms Kurincic is considered an independent director under the Company’s definition of independence. Ms Kurincic is a member of the Audit, Risk & Compliance Committee and the Remuneration and Nomination Committee.

Kathy Parsons

Non-Executive Director Chair of the Audit, Risk and Compliance Committee

Ms Parsons is a former audit partner at Ernst & Young where she spent time as a partner in the firm’s US, UK and Australian practices. In addition to her audit client responsibilities she was part of the firm’s Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. Ms Parsons is considered an independent Director under the Company’s definition of independence. Ms Parsons is Chair of the Audit, Risk and Compliance Committee and a member of the Remuneration and Nomination Committee.

Bruce Akhurst

Non-Executive Director
Chairman of the People, Culture and Remuneration Committee

Mr Akhurst is currently the Chairman of Tabcorp Holdings Limited and a member of the Audit Committee, Technology Committee, Nomination Committee, People and Remuneration Committee and interim Chair of the Risk, Compliance and Sustainability Committee. Mr Akhurst is also Chair of the Peter MacCallum Cancer Foundation and Council Member of RMIT University chairing the Infrastructure and Information Technology Committee. Mr Akhurst was previously the CEO of Sensis, Group MD and General Counsel of Telstra and a Partner of Mallesons Stephen Jaques.

Mr Akhurst is considered an independent director under the Company’s definition of independence.

Mr Akhurst is a member of the Audit, Risk and Compliance Committee.

Rob De Luca

Chief Executive Officer

Having joined MMS in 2022, Mr De Luca has over 20 years’ experience in Financial Services, Wealth Management, Disability and Healthcare, including roles as Managing Director of Bankwest, CEO of the National Disability Insurance Agency (NDIA) and most recently as CEO of Zenitas Healthcare.